Not Signed In -
Lansoprazole |
Prevacid |
Lansoprazole Systematic (IUPAC) name 2-[(3-methyl-4-(2,2,2-trifluoroethoxy) pyridin-2-yl) methylsulfinyl] -1H-benzoimidazole Identifiers CAS number 103577-45-3 ATC code A02BC03 PubChem 3883 DrugBank APRD00077 Chemical data Formula C16H14F3N3OS Mol. weight 369.363 Pharmacokinetic data Bioavailability 80% or more Metabolism Hepatic Half life 1 - 1.5 hours Excretion Renal Fecal Therapeutic considerations Pregnancy cat. ? Legal status ? Routes Ora ...
Wikipedia - [full article]
Lansoprazole Clinical Trials
- Efficacy of Lansoprazole in Chronic Post Nasal Drip
ClinicalTrials.gov Identifier: NCT00335283 - Recruiting
Larynx Disease
- Lansoprazole Preventing Gastroduodenal Stress Ulcerations
ClinicalTrials.gov Identifier: NCT00220909 - Recruiting
Patients Undergoing Elective Coronary Artery Bypass Graft
- Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis
ClinicalTrials.gov Identifier: NCT00471094 - Active, not recruiting
Esophagitis
- Pharmacokinetic Study of Lansoprazole in Cystic Fibrosis
ClinicalTrials.gov Identifier: NCT00458614 - Active, not recruiting
Cystic Fibrosis
- Safety and Efficacy of Lansoprazole 30mg Twice Daily in Treatment of Laryngitis Associated With Gastroesophageal Reflux.
ClinicalTrials.gov Identifier: NCT00369265 - Recruiting
Laryngopharyngeal Reflux
- A Randomized, Single-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.
ClinicalTrials.gov Identifier: NCT00237068 - Recruiting
Asthma
- Lansoprazole to Treat Children With Asthma
ClinicalTrials.gov Identifier: NCT00442013 - Recruiting
Asthma
- Tailored Treatment of H. Pylori Infection Based on SNPs of CYP2C19 and 23S rRNA of H. Pylori
ClinicalTrials.gov Identifier: NCT00149084 - Recruiting
H. pylori infection; Gastritis; Gastric ulcer; Duodenal Ulcer
- Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD
ClinicalTrials.gov Identifier: NCT00410592 - Completed
Gastroesophageal Reflux Disease
- Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis.
ClinicalTrials.gov Identifier: NCT00175045 - Completed
Esophagitis; Reflux
- Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn
ClinicalTrials.gov Identifier: NCT00389948 - Completed
Heartburn
- Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn
ClinicalTrials.gov Identifier: NCT00390390 - Completed
Heartburn
- A Study to Compare the Efficacy and Safety of Dexlansoprazole and Lansoprazole on Healing of Erosive Esophagitis
ClinicalTrials.gov Identifier: NCT00251693 - Completed
Esophagitis, Reflux; Esophagitis, Peptic
- A Study to Compare the Efficacy and Safety of Dexlansoprazole and Lansoprazole on Healing of Erosive Esophagitis
ClinicalTrials.gov Identifier: NCT00251719 - Completed
Esophagitis, Reflux; Esophagitis, Peptic
- An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients
ClinicalTrials.gov Identifier: NCT00352261 - Completed
Barrett's Esophagus
- Study of 24-Hour Intragastric pH Profiles of Esomeprazole 40 Mg and Lansoprazole 30 Mg in Healthy Volunteer Subjects
ClinicalTrials.gov Identifier: NCT00230516 - Completed
Healthy
- The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal Reflux
ClinicalTrials.gov Identifier: NCT00324974 - Completed
Gastroesophageal Reflux Disease
- A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux Disease.
ClinicalTrials.gov Identifier: NCT00174928 - Completed
Gastroesophageal Reflux Disease
- A Study to Evaluate the Effect of Lansoprazole on Infants With Gastroesophageal Reflux Disease.
ClinicalTrials.gov Identifier: NCT00220818 - Completed
Gastroesophageal Reflux Disease
Resources
- Lansoprazole (Drug Digest)
- Prevacid (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
